Evidence map›Paper›PMID 19009282›Full record

ReviewJournal of molecular medicine (Berlin, Germany)2009

Age-related macular degeneration: activation of innate immunity system via pattern recognition receptors.

K Kaarniranta, A Salminen

Abstract readReview
PubMed Publisher
In one paragraph

Review in Journal of molecular medicine (Berlin, Germany), 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
5.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 75 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. The emerging role of extracellular vesicles in retinal diseases.American journal of translational research · 2021
    Review
  11. Article
  12. Article
  13. Article
  14. Evidence for an Association between Macular Degeneration and Thyroid Cancer in the Aged Population.International journal of environmental research and public health · 2018
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Inflammation and its role in age-related macular degeneration.Cellular and molecular life sciences : CMLS · 2016
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

K KaarnirantaDepartment of Ophthalmology, Institute of Clinical Medicine, University of Kuopio, P.O. Box 1627, 70211, Kuopio, Finland. kai.kaarniranta@uku.fi
A Salminen
Kuopio University Hospital · FIUniversity of Eastern Finland · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Age-related macular degeneration (AMD) is the most common cause of irreversible loss of central vision. Histopathological studies have demonstrated that inflammation is the key player in the pathogenesis of AMD. Genetic studies have revealed that complement factor H is a strong risk factor for the development of AMD. However, innate immunity defence involves several other pattern recognition receptors (PRRs) which can trigger inflammatory responses. Retinal pigment epithelial (RPE) cells have the main role in the immune defence in macula. In this study, we examine in detail the endogenous danger signals which can activate different PRRs in RPE cells, such as Toll-like, NOD-like and scavenger receptors along with complement system. We also characterise the signalling pathways triggered by PRRs in evoking inflammatory responses. In addition, we will discuss whether AMD pathology could represent the outcome of chronic activation of the innate immunity defence in human macula.

Indexed as

AnimalsComplement Factor HHumansImmunity, InnateInflammationMacular DegenerationModels, BiologicalPolymorphism, GeneticReceptors, Pattern RecognitionToll-Like ReceptorsComplement Factor HReceptors, Pattern RecognitionToll-Like Receptors

Identifiers

PMID19009282
OpenAlexW2112146496

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.